✦ LIBER ✦

S-1-based therapy versus 5-FU-based therapy in advanced gastric cancer: a meta-analysis

✍ Scribed by Jiahao Huang; Yunfei Cao; Liucheng Wu; Cun Liao; Yongming He; Feng Gao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S-1-based therapy versus S-1 monotherapy

✍ Wu, Jun-Rong; Tang, Wei-Zhong; Chen, Xi; Xie, Yan-Tong; Chen, Si-Yuan; Peng, Qi- 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 547 KB

S-1-based versus 5-FU-based chemotherapy

✍ Li, Dan-Hong; Pan, Zhen-Kui; Ye, Feng; An, Han-Xiang; Wu, Jing-Xun 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 594 KB

Letter regarding Wu JR et al.: S-1-based

✍ Lin, Jinhai; Li, Zeling; Li, Meixiang; He, Shaozhong 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 71 KB

Cetuximab-based therapy versus non-cetux

✍ Lidan Liu; Yunfei Cao; Aihua Tan; Cun Liao; Feng Gao 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 633 KB

Gemcitabine-based doublets versus single

✍ Antonio Russo; Sergio Rizzo; Fabio Fulfaro; Vincenzo Adamo; Daniele Santini; Bru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB

Cost-effectiveness analysis of irinoteca

✍ A. Bearne; A. Burrell 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 345 KB